Literature DB >> 18079052

Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.

Tess V Clendenen1, Alan A Arslan, Karen L Koenig, Kerstin Enquist, Isaac Wirgin, Asa Agren, Annekatrin Lukanova, Hubert Sjodin, Anne Zeleniuch-Jacquotte, Roy E Shore, Göran Hallmans, Paolo Toniolo, Eva Lundin.   

Abstract

The vitamin D receptor (VDR) is a critical mediator of the cellular effects of vitamin D. The associations between four common VDR polymorphisms (BSMI, APAI, TAQI, and FOKI) and risk of epithelial ovarian cancer (EOC) were assessed in a case-control study nested within two prospective cohorts. One hundred seventy incident cases of EOC and 323 individually matched controls were genotyped. Overall, no associations were observed in genotype analyses. Haplotypes combining three SNPs in high linkage disequilibrium (BSMI, APAI, and TAQI) were also not associated with risk. These observations do not support a role for BSMI, APAI, TAQI, and FOKI polymorphisms in epithelial ovarian cancer in a predominantly Caucasian population.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18079052      PMCID： PMC2259240          DOI： 10.1016/j.canlet.2007.11.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  18 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 2.  Vitamin D and cancer.

Authors:  Roger Bouillon; Guy Eelen; Lieve Verlinden; Chantal Mathieu; Geert Carmeliet; Annemieke Verstuyf
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

3.  Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques.

Authors:  Peter Kraft; David G Cox; Randi A Paynter; David Hunter; Immaculata De Vivo
Journal:  Genet Epidemiol       Date:  2005-04       Impact factor: 2.135

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women.

Authors:  H Arai; K Miyamoto; Y Taketani; H Yamamoto; Y Iemori; K Morita; T Tonai; T Nishisho; S Mori; E Takeda
Journal:  J Bone Miner Res       Date:  1997-06       Impact factor: 6.741

Review 6.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.

Authors:  Michael F Holick
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

7.  Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study.

Authors:  D M Freedman; M Dosemeci; K McGlynn
Journal:  Occup Environ Med       Date:  2002-04       Impact factor: 4.402

8.  Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions.

Authors:  Göran Hallmans; Asa Agren; Gerd Johansson; Anders Johansson; Birgitta Stegmayr; Jan-Håkan Jansson; Bernt Lindahl; Olle Rolandsson; Stefan Söderberg; Mats Nilsson; Ingegerd Johansson; Lars Weinehall
Journal:  Scand J Public Health Suppl       Date:  2003       Impact factor: 3.021

Review 9.  Genetics and biology of vitamin D receptor polymorphisms.

Authors:  André G Uitterlinden; Yue Fang; Joyce B J Van Meurs; Huibert A P Pols; Johannes P T M Van Leeuwen
Journal:  Gene       Date:  2004-09-01       Impact factor: 3.688

10.  Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

Authors:  D Ford; D F Easton; J Peto
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025
View more
  21 in total

1.  Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Michael E Carney; Rachel T Palmieri; Paul D P Pharoah; Honglin Song; Estrid Hogdall; Susanne Kruger Kjaer; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Marc T Goodman
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

Review 2.  Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.

Authors:  Yeqiong Xu; Bangshun He; Yuqin Pan; Qiwen Deng; Huiling Sun; Rui Li; Tianyi Gao; Guoqi Song; Shukui Wang
Journal:  Tumour Biol       Date:  2014-01-10

3.  Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations.

Authors:  Adrianna Mostowska; Stefan Sajdak; Piotr Pawlik; Margarita Lianeri; Paweł P Jagodzinski
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

4.  The VDR gene FokI polymorphism and ovarian cancer risk.

Authors:  Hui Xu; Su Li; Jian-Qing Qiu; Xiao-Lin Gao; Ping Zhang; Yong-Xia Yang
Journal:  Tumour Biol       Date:  2013-12

5.  Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population.

Authors:  Adrianna Mostowska; Stefan Sajdak; Piotr Pawlik; Margarita Lianeri; Pawel P Jagodzinski
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-15

6.  Sun exposure and risk of epithelial ovarian cancer.

Authors:  Clara Bodelon; Kara L Cushing-Haugen; Kristine G Wicklund; Jennifer A Doherty; Mary Anne Rossing
Journal:  Cancer Causes Control       Date:  2012-10-12       Impact factor: 2.506

7.  Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Wei Zheng; Kim N Danforth; Shelley S Tworoger; Marc T Goodman; Alan A Arslan; Alpa V Patel; Marjorie L McCullough; Stephanie J Weinstein; Laurence N Kolonel; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Emily Steplowski; Kala Visvanathan; Kai Yu; Anne Zeleniuch-Jacquotte; Yu-Tang Gao; Susan E Hankinson; Chinonye Harvey; Richard B Hayes; Brian E Henderson; Ronald L Horst; Kathy J Helzlsouer
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

8.  Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.

Authors:  Shelley S Tworoger; Margaret A Gates; Margaret A Gate; I-Min Lee; Julie E Buring; Linda Titus-Ernstoff; Daniel Cramer; Susan E Hankinson
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

9.  Circulating vitamin d and risk of epithelial ovarian cancer.

Authors:  Alan A Arslan; Tess V Clendenen; Karen L Koenig; Johan Hultdin; Kerstin Enquist; Asa Agren; Annekatrin Lukanova; Hubert Sjodin; Anne Zeleniuch-Jacquotte; Roy E Shore; Göran Hallmans; Paolo Toniolo; Eva Lundin
Journal:  J Oncol       Date:  2009-08-27       Impact factor: 4.375

10.  Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.

Authors:  S Tamez; C Norizoe; K Ochiai; D Takahashi; A Shimojima; Y Tsutsumi; N Yanaihara; T Tanaka; A Okamoto; M Urashima
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.